Composition Typically formulated as a combined 10 mg vial, commonly: 5 mg CJC-1295 (No DAC) 5 mg Ipamorelin Total = 10 mg blended peptide content Physical form Lyophilised (freeze-dried) sterile powder Stored in sealed laboratory-grade vial Designed for reconstitution in controlled research environments only Research classification This blend is studied in experimental endocrinology and peptide signalling research , focusing on: Growth hormone pulse regulation GHRH and ghrelin receptor pathway interaction Endocrine signalling dynamics Receptor co-activation and feedback mechanisms Hormonal rhythm and secretion pattern modelling Mechanism overview (research context) This combination pairs two different biological pathways: CJC-1295 (No DAC): a modified growth hormone-releasing hormone (GHRH) analog that stimulates pituitary GH release in a short, pulsatile manner Ipamorelin: a selective growth hormone secretagogue that activates the ghrelin receptor (GHS-R1a) to amplify GH pulses Together, they are used in research to model synergistic, dual-pathway GH secretion and study how multiple receptor systems interact Key laboratory interest Researchers commonly use this blend to investigate: Natural-like pulsatile GH signalling patterns Interaction between GHRH and ghrelin systems Endocrine feedback loop behaviour Tissue growth signalling cascades (in vitro / preclinical models) Peptide receptor cross-talk dynamics Stability & handling Lyophilised form improves shelf stability Typically stored frozen before reconstitution (research protocol dependent) After reconstitution, refrigerated conditions are commonly used in lab settings Regulatory status Not approved for human or veterinary use Not a licensed medicinal product Supplied strictly as research chemical / laboratory reagent Intended for qualified research environments only

Notably though, the accompanying treatment algorithms do not explicitly recommend combination therapy
In the landmark study that introduced it, published in Cell Metabolism (Lee et al., 2015), researchers showed that MOTS-c regulates insulin sensitivity and metabolic homeostasis through the AMPK pathway, and that treatment prevented diet-induced obesity and insulin resistance in animal models
Bacteriostatic water (0.9% benzyl alcohol in sterile water) prevents bacterial growth it does not prevent peptide bond hydrolysis, oxidation, or aggregation, which are chemical processes driven by temperature and time
61 ECC5004 The preliminary results of the investigational agent ECC5004 phase 1 trial in non-human primates revealed a reduction in HbA1c levels, accompanied by weight loss and a decreased risk of adverse cardiovascular events, achieved through the mimicry of the hormone GLP-1